- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01751594
Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men
28. juli 2017 opdateret af: University of North Carolina, Chapel Hill
The proposed research study aims to conduct a culturally-based secondary prevention intervention targeted toward HIV-positive Black young men who have sex with men (B-YMSM) to explore (1) feasibility and acceptability (Trial 1 and Trial 2) and (2) evidence of potential efficacy (Trial 2).
The primary outcomes will be health promotion behaviors (i.e., treatment adherence, sexual risk reduction, reduction in substance use behaviors, and HIV status disclosure).
Psychosocial factors (i.e.
self-esteem, critical consciousness, and socio-political awareness) will be examined as secondary outcomes.
Studieoversigt
Status
Afsluttet
Intervention / Behandling
Detaljeret beskrivelse
First, the protocol team will finalize the development and manualization of Health 4 Life (H4L) a comparison intervention, which will serve as the basis of comparison for Mobilizing Our Voices for Empowerment (MOVE), the treatment intervention.
H4L will be a health promotion and life skills intervention to account for time and attention.
Following this the protocol team will then implement Trial 1.
In this trial, the intervention specialist and a "peer buddy" (intervention co-facilitator) from one AMTU will conduct one wave of both MOVE and H4L.
The team will then conduct an analysis of the process data and revise the two interventions (MOVE and H4L).
Upon revising the interventions, the protocol team will implement Trial 2. In this trial, the protocol co-chairs and the interventionist from Trial 1 will train interventionists and peer buddies from four new AMTUs; these interventionists and peer buddies will run the revised MOVE and H4L interventions.
Each site will be designated as either a treatment or comparison site, and they will conduct two waves of their assigned intervention.
The team at that time will conduct data analyses and then modify and manualize the final version of MOVE and H4L.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
92
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90027
- Children's Hospital of Los Angeles
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- Stroger Hospital and the CORE Center
-
-
New York
-
The Bronx, New York, Forenede Stater, 10467
- Montefiore Medical Center
-
-
Tennessee
-
Memphis, Tennessee, Forenede Stater, 38105
- St. Jude Children'S Research Hospital
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Baylor College of Medicine - Texas Children's Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
16 år til 24 år (Barn, Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Han
Beskrivelse
To be considered eligible for enrollment into Trial 1 and Trial 2, an individual must meet the criteria listed below:
- Receives services at one of the selected AMTU sites or one of their community partners;
- Biological male at birth and self identifies as male gender at the time of consent;
- Self identifies as "Black" (including Black/African-American, Black Latino, Black/Afro-Caribbean, Black/African immigrant, or any self-identified member of the African Diaspora);
- HIV-infected as documented by medical record review or verification with referring medical professional;
- Between the ages of 16-24 years, inclusive, at the time of consent;
- HIV-infected through sexual behavior;
- At least one sexual encounter involving oral or anal sex with a male partner in the past year;
- Ability to understand both written and spoken English;
- Willingness to participate in a group-based intervention with other HIV-positive B-YMSM and agree to respect the privacy of other group members;
- Willingness and ability to attend the first group session on any of the date chosen by the site staff and;
- Willingness to provide signed informed consent or assent with parental/legal guardian permission as applicable.
To be considered eligible for enrollment, an individual must not meet any of the criteria listed below.
- Active psychiatric condition that in the opinion of the site personnel would interfere with the ability to give true informed consent and to adhere to the study requirements;
- Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior);
- Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with the ability to give true informed consent and to adhere to the study requirements;
- Acute illness that, in the opinion of the treating clinician, would interfere with the participant's ability to adhere to the protocol requirements and/or interfere with the protocol objectives.
- Previous participation in ATN 090, "Development of a Secondary Prevention Intervention Targeting HIV-Positive Black Young Men Who have Sex with Men." (NOTE: YAB members from ATN090 cannot participate in ATN 104)
- Previous participation in Trial 1 of ATN104 and;
- Current enrollment in any other behavioral intervention study or program. Any cases that are uncertain require Protocol Team approval.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: H4L Comparison Intervention
|
Health 4 Life (H4L) is a comparison intervention which will serve as the basis of comparison for Mobilizing Our Voices for Empowerment (MOVE), the treatment intervention.
H4L will be a health promotion and life skills intervention to account for time and attention.
|
Eksperimentel: MOVE Intervention
|
MOVE involves four sessions.
Sessions 1 and 2 occur over a two-day time frame and are each one day long (approximately 8 hours in length).
They will: lay the groundwork for the intervention; provide HIV and other sexual health-related information; introduce critical consciousness; Sessions 1 and 2 will begin the enhancement of critical consciousness and the action-reflection-action cycle.
Sessions 3 and 4 are also one-day sessions each (approximately 8 hours in length) and will be administered at one month intervals following the completion of sessions 1 and 2. These sessions will be used to provide continued enhancement of critical consciousness and guided support, feedback, and social reinforcement for behavior change and self-efficacy related to increasing health-promoting behaviors and reducing HIV-related health risk behaviors.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Finalize and manualize a critical consciousness based intervention for HIV positive B-YMSM
Tidsramme: 2 years
|
To finalize and manualize Mobilizing Our Voices for Empowerment (MOVE) resulting in an intervention with evidence of potential efficacy in reducing sexual risk and substance use behaviors and promoting treatment adherence and HIV status disclosure, as well as self-esteem, critical consciousness, and socio-political awareness.
At the same time a non-critical consciousness intervention Health 4 Life (H4L) which will be used as comparison will also be finalized and manualized.
H4L is primarily a health promotion and life skills intervention for HIV-positive B-YMSM.
|
2 years
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Studiestol: Gary Harper, PhD, DePaul University
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. april 2012
Primær færdiggørelse (Faktiske)
1. juni 2014
Studieafslutning (Faktiske)
1. juni 2014
Datoer for studieregistrering
Først indsendt
14. december 2012
Først indsendt, der opfyldte QC-kriterier
14. december 2012
Først opslået (Skøn)
18. december 2012
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
1. august 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. juli 2017
Sidst verificeret
1. marts 2016
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ATN 104
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutteringHIV | HIV-testning | HIV-kobling til pleje | HIV behandlingForenede Stater
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationAfsluttetPartner HIV-testning | Par HIV Rådgivning | Parkommunikation | HIV-forekomstCameroun, Dominikanske republik, Georgien, Indien
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement og andre samarbejdspartnereUkendtHIV | HIV-uinficerede børn | Børn udsat for HIVCameroun
-
University of MinnesotaTrukket tilbageHIV-infektioner | HIV/AIDS | Hiv | AIDS | Aids/Hiv problem | AIDS og infektionerForenede Stater
-
CDC FoundationGilead SciencesUkendtHIV præeksponeringsprofylakse | HIV KemoprofylakseForenede Stater
-
Erasmus Medical CenterIkke rekrutterer endnuHIV-infektioner | Hiv | HIV-1-infektion | HIV I infektionHolland
-
Hospital Clinic of BarcelonaAfsluttetIntegrasehæmmere, HIV; HIV PROTEASE HÆMMERSpanien
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London og andre samarbejdspartnereRekrutteringHIV | HIV-testning | Tilknytning til plejeSydafrika
-
University of WashingtonNational Institute of Mental Health (NIMH)RekrutteringHIV-forebyggelse | HIV præeksponeringsprofylakse | ImplementeringKenya
-
University of Maryland, BaltimoreTrukket tilbageHiv | Nyretransplantation | HIV reservoir | CCR5Forenede Stater
Kliniske forsøg med H4L Comparison Intervention
-
University of California, Los AngelesAfsluttetØjensygdomme | Kroniske nyresygdomme | Lændesmerter | Kirurgi | HjertesygdomForenede Stater
-
University of PennsylvaniaAktiv, ikke rekrutterendeForhøjet blodtrykForenede Stater
-
Denver Health and Hospital AuthorityAfsluttetChok, septisk | Samfundserhvervet lungebetændelse
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health...Afsluttet
-
Women's College HospitalAfsluttetSportsfysioterapi | ACL skadeCanada
-
University of Southern CaliforniaAgency for Healthcare Research and Quality (AHRQ); Teladoc HealthAfsluttetAkut luftvejsinfektion | TelesundhedForenede Stater
-
University of HoustonIkke rekrutterer endnuPost traumatisk stress syndrom | Farligt drikkeriForenede Stater
-
Florida State UniversityUniversity of North Carolina, Chapel Hill; University of GeorgiaTilmelding efter invitationKardiovaskulær sygdom risikoreduktionForenede Stater
-
Biolux Research Holdings, Inc.AfsluttetOrtodontisk tandbevægelseCanada
-
University of FloridaAfsluttetFølsomhedForenede Stater